AXL knockout does not prevent dormancy.

Slides:

Advertisements

Similar presentations

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.

Advertisements

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.

Volume 3, Issue 6, Pages (June 2003)

TLR5 signaling in murine bone marrow induces hematopoietic progenitor cell proliferation and aids survival from radiation by Benyue Zhang, Damilola Oyewole-Said,

In vivo responses of AMLMLL to ATRi.

Fig. 8. In vivo suppression of MM by CMLD

BV6 increases tumor burden in bone.

The STM1787 promoter in Salmonella is rapidly activated in vivo by the tumor microenvironment. The STM1787 promoter in Salmonella is rapidly activated.

Acute, systemic Atg7 deficiency compromises tumorigenesis.

Functional interaction of Eμ-Tcl1 tumor cells with FDC networks.

Volume 152, Issue 1, Pages (January 2019)

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Fig. 8 SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and in vivo. SQLE inhibitor terbinafine suppresses NAFLD-HCC growth in vitro and.

Myeloma cell–derived Runx2 promotes myeloma progression in bone

Marta Vilalta, Marjan Rafat, Amato J. Giaccia, Edward E. Graves

Bioluminescence imaging facilitates detection of tumor growth and metastasis in mouse orthotopic xenograft model. Bioluminescence imaging facilitates detection.

CXCR5 expression accelerates Eμ-Tcl1 leukemogenesis and is indispensable for tumor cell recruitment to lymphoid B-cell follicles. CXCR5 expression accelerates.

Overexpression of HGF decreases MET protein levels.

Katelyn T. Byrne, Robert H. Vonderheide Cell Reports

Volume 19, Issue 1, Pages (April 2017)

Src acetylation is critical for its tumorogenesis property.

Mouse lymphoma model. Mouse lymphoma model. A, EL-Arf−/− cells (1 × 106) were tail-vein injected into C57BL/6 mice. LNIWC imaging was separated into 2.

Dox administration was required for Tet-CD19CAR T cells to show a suppressive function against a CD19+ tumor in vivo. Dox administration was required for.

A, rate of proliferation of PC3 prostate cancer cells is greatly reduced by treatment with oligomers containing CpG motifs, as assessed by (a) soft agar.

Effect of HA on hematopoietic recovery in tumor-bearing mice.

Subcutaneous tumor growth was significantly increased in Ogt-Tg/+ mice

Tumor MMP-1 functionally regulates the permeability of endothelial cell barriers and contributes to HEp3-hi/diss transendothelial migration. Tumor MMP-1.

The selective depletion of DTR-expressing FAP+/CD45+ and FAP+/CD45− tumoral cells from bone marrow chimeric mice by the administration of DTX. A, sketch.

PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant p53 in vivo. PRIMA-1Met inhibits the growth of multiple myeloma tumors with mutant.

AXL is not expressed in human prostate tumors.

Quercetin induces arrest in G1 phase of cell cycle in P39 xenografts.

Histopathology of anal tissue.

EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo. EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo.

Runx3 combined deletion in DCs and thymocytes fully recapitulates Runx3-null tumor resistance. Runx3 combined deletion in DCs and thymocytes fully recapitulates.

IDO deficiency delays the development of pulmonary metastases.

N-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. n-3 PUFAs promote endometrial cancer cell apoptosis in vitro and in vivo. HEC-1-A.

ESKM is superior to ESK1 in vivo, and is effective against multiple tumor models. ESKM is superior to ESK1 in vivo, and is effective against multiple tumor.

CLIC1 supports invadopodia formation in vitro and metastasis in vivo.

Essential role for the overexpression of type I IFN-related genes in the improved chemotherapeutic response of Stat3−/− tumors. Essential role for the.

Tumor cell clusters with increased tumorigenesis, metastasis, and CD44 expression. Tumor cell clusters with increased tumorigenesis, metastasis, and CD44.

Fig. 6 Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9 in vivo. Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9.

CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. CD44 depletion blocks tumor cell aggregation and lung metastasis in vivo. A,

Activation status of CD8+ T cells.

Tumor-resident CD8+ T cells rapidly expand after IL-15/IL-15Rα complex treatment. Tumor-resident CD8+ T cells rapidly expand after IL-15/IL-15Rα complex.

Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.

Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.

Anti-CD40 activates TAMs and recruits inflammatory monocytes.

AR inhibition decreases ER+/AR+ breast cancer growth.

A, transversal and coronal microPET images of 89Zr-ranibizumab at 24 hours pi of the tracer. A, transversal and coronal microPET images of 89Zr-ranibizumab.

SPARC is required for spontaneous metastasis

Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors. Efficacy of KM100 and/or MTX in BALB/c mice bearing subcutaneous TUBO tumors.

Effect of MZ treatment on lung colony formation in an experimental metastasis. Effect of MZ treatment on lung colony formation in an experimental metastasis.

Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.

Interaction of NHEJ and HR pathways in PCO cultures.

AXL overexpression decreases proliferation in vitro.

Effects of ZOL treatment on pulmonary metastases.

Effect of dexamethasone on PCDGF/GP88 mRNA and protein expressions and effect of PCDGF/GP88 on dexamethasone-induced cell death. Effect of dexamethasone.

Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.

BV6 increases bone metastasis.

Enhanced antitumor effects with combination IL21 and anti–PD-1/anti–Tim-3 therapy. Enhanced antitumor effects with combination IL21 and anti–PD-1/anti–Tim-3.

CPI-444 synergizes with anti–PD-L1 and anti–CTLA-4 treatment.

NF1-associated and sporadic MPNST cell lines show a decrease in cell viability, soft agar colony formation, and xenograft tumor growth when Wnt/β-catenin.

Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated breast cancer cells. Elevated STAT3 phosphorylation and RANTES levels in tamoxifen-treated.

AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,

Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells. Curcumin decreases viability and proliferation of Bcr-Abl-expressing cells.

BH3-targeted inhibitors drive specific resistance in human cell lines, which can be overcome with alternating or combining inhibitors. BH3-targeted inhibitors.

Dose-dependent effect of IP6 feeding on angiogenesis in prostate of TRAMP mice. Dose-dependent effect of IP6 feeding on angiogenesis in prostate of TRAMP.

Hoxa9 is partly required for Twist1-induced migration, invasion, anoikis resistance, and soft agar tumorigenicity of Myc-CaP cells. Hoxa9 is partly required.

Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.

Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced.

Presentation transcript:

AXL knockout does not prevent dormancy. AXL knockout does not prevent dormancy. A, Western blot showing AXL expression (left) in PC3 cells seeded at various densities (right, phase images; n = 1). Arrow represents 125 kDa. Scale bar, 500 μm. B, AXL expression by Western blot in PC3 cells (Par), a control knockout clone (Cntl KO), and two AXL knockout clones (Axl KO1 and Axl KO 2; n = 1). Arrow represents 125 kDa. C, BrdUrd incorporation over 24 hours in control and knockout cell lines ± GAS6. Results represent fold change between the incorporation readout on days 6 to 2 (n = 3). Error bars, mean ± SEM; P values calculated using the t test between Axl KO and Cntl KO, and within each cell line between treatments. D, Quantification of the number of large colonies (number of colonies in the top 65% of the range of colony size) in soft agar ± GAS6, relative to reference sample Par -GAS6 (n = 3). Error bars, mean ± SEM; P values calculated using multiple t-tests to assess differences due to treatment. E, Number and proliferation status of bone marrow DTCs detected in mice at 1 week after intracardiac injection. Each bar represents 1 mouse (n = 7 per group). F, Time in days to tumorigenesis after intracardiac injection. Tumorigenesis was defined as BLI signal over control PBS-injected mice (Cntl KO, n = 9; Axl KO, n = 12; each dot represents one mouse; mean ± SD). G, Duration of tumor growth of each group after intracardiac injection. Duration of growth was defined as the time between the onset of tumorigenesis and time to lethal tumor burden (Cntl KO, n = 9; Axl KO, n = 12; each dot represents one mouse; mean ± SD). H, Survival proportions for each group of mice over time (Cntl KO, n = 9 mice; Axl KO, n = 12 mice). P value calculated by the log-rank test. For relevant experiments, GAS6 was added at 100 ng/mL at the time of seeding. For mouse tumor growth P values were calculated by the t test. I, Number and proliferation status of bone marrow DTCs detected in mice at the time of death. Counting stopped after the first 500 BM-DTCs (n = 5 for each group). Haley D. Axelrod et al. Mol Cancer Res 2019;17:356-369 ©2019 by American Association for Cancer Research